Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
KEWAUNEE SCIENTIFIC CORP /DE/ incurred revolving credit of up to $15.0 million with Mid Cap Funding IV Trust, as agent at Term SOFR plus 4.10% maturing December 19, 2025.
- Instrument
- revolving credit
- Principal
- up to $15.0 million
- Counterparty
- Mid Cap Funding IV Trust, as agent
- Rate
- Term SOFR plus 4.10%
- Maturity
- December 19, 2025
- Event
- incurrence
Exact text from the filing
On December 19, 2022, Kewaunee Scientific Corporation (the “Company”) entered into a Credit and Security Agreement (the “Credit Agreement”) with Mid Cap Funding IV Trust, as agent (the “Agent”), and the lenders from time to time party thereto (collectively, the “Lenders”). The Credit Agreement provides for a secured revolving line of credit initially of up to $15.0 million (the “Revolving Credit Facility”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
KEWAUNEE SCIENTIFIC CORP /DE/ entered into Credit Agreement with Mid Cap Funding IV Trust, as agent (the “Agent”), and the lenders from time to time party thereto valued at $15.0 million (effective 2022-12-19).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Mid Cap Funding IV Trust, as agent (the “Agent”), and the lenders from time to time party thereto
- Value
- $15.0 million
- Effective
- 2022-12-19
Exact text from the filing
On December 19, 2022, Kewaunee Scientific Corporation (the “Company”) entered into a Credit and Security Agreement (the “Credit Agreement”) with Mid Cap Funding IV Trust, as agent (the “Agent”), and the lenders from time to time party thereto (collectively, the “Lenders”). The Credit Agreement provides for a secured revolving line of credit initially of up to $15.0 million (the “Revolving Credit Facility”).
View on SEC.gov